Skip to Content
Top

BY Laura Sussman

MD Anderson researchers are proposing a new model to allow doctors to predict outcomes more accurately for patients with oropharyngeal (middle throat) cancers specifically caused by the human papillomavirus (HPV).

The current staging model fails to separate oropharyngeal cancer cases caused by the HPV virus from oropharyngeal cancer cases caused by smoking and alcohol. Thus, the researchers sought to develop a revised staging system...

BY Ron Gilmore

New findings about where and how aggressive forms of prostate cancer potentially begin may lead to new therapies for hard-to-treat and lethal...

BY Ron Gilmore

ONC201, an anti-cancer drug that triggers cell death in various tumor types, may be effective in treating some blood cancers, including mantle...

BY Clayton Boldt, Ph.D.

Looking at data from a standard technology in a novel way, MD Anderson researchers have discovered that certain genetic aberrations are two to three times more common in healthy tissue than previously reported.

This study, published last week in the American Journal of Human Genetics, may guide future work to learn how these changes could be used as prognostic markers for cancer risk.

Genetic mosaicism is a phenomenon described...

BY Scott Merville

The nation’s premier cancer research group, oncology society and 20 other organizations recently released a statement calling for state and...